Global and United States Microbiome Therapeutics and Diagnostics Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Market Analysis and Insights: Global and United States Microbiome Therapeutics and Diagnostics Market
This report focuses on global and United States Microbiome Therapeutics and Diagnostics market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Microbiome Therapeutics and Diagnostics market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, FMT accounting for % of the Microbiome Therapeutics and Diagnostics global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Stomach was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Microbiome Therapeutics and Diagnostics market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period.

Global Microbiome Therapeutics and Diagnostics Scope and Market Size
Microbiome Therapeutics and Diagnostics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Microbiome Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Microbiome Therapeutics and Diagnostics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Microbiome Therapeutics and Diagnostics market is segmented into
    FMT
    Microbiome Drugs
    Others

Segment by Application, the Microbiome Therapeutics and Diagnostics market is segmented into
    Stomach
    Respiratory Tract
    Other

Regional and Country-level Analysis
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Microbiome Therapeutics and Diagnostics Market Share Analysis
Microbiome Therapeutics and Diagnostics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Microbiome Therapeutics and Diagnostics business, the date to enter into the Microbiome Therapeutics and Diagnostics market, Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:
    4D Pharma
    Capsugel
    Gusto Global
    MatriSys Bioscience
    Pierre Fabre
    Sunstone Capital

 1 Study Coverage
    1.1 Microbiome Therapeutics and Diagnostics Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Microbiome Therapeutics and Diagnostics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Microbiome Therapeutics and Diagnostics Market Size for the Year 2017-2028
        1.2.2 Global Microbiome Therapeutics and Diagnostics Market Size for the Year 2017-2028
    1.3 Microbiome Therapeutics and Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Microbiome Therapeutics and Diagnostics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Microbiome Therapeutics and Diagnostics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Microbiome Therapeutics and Diagnostics Market Dynamics
        1.4.1 Microbiome Therapeutics and Diagnostics Industry Trends
        1.4.2 Microbiome Therapeutics and Diagnostics Market Drivers
        1.4.3 Microbiome Therapeutics and Diagnostics Market Challenges
        1.4.4 Microbiome Therapeutics and Diagnostics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered

 2 Microbiome Therapeutics and Diagnostics by Type
    2.1 Microbiome Therapeutics and Diagnostics Market Segment by Type
        2.1.1 FMT
        2.1.2 Microbiome Drugs
        2.1.3 Others
    2.2 Global Microbiome Therapeutics and Diagnostics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2028)
    2.4 United States Microbiome Therapeutics and Diagnostics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2028)

 3 Microbiome Therapeutics and Diagnostics by Application
    3.1 Microbiome Therapeutics and Diagnostics Market Segment by Application
        3.1.1 Stomach
        3.1.2 Respiratory Tract
        3.1.3 Other
    3.2 Global Microbiome Therapeutics and Diagnostics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2028)
    3.4 United States Microbiome Therapeutics and Diagnostics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2028)

 4 Global Microbiome Therapeutics and Diagnostics Competitor Landscape by Company
    4.1 Global Microbiome Therapeutics and Diagnostics Market Size by Company
        4.1.1 Top Global Microbiome Therapeutics and Diagnostics Companies Ranked by Revenue (2021)
        4.1.2 Global Microbiome Therapeutics and Diagnostics Revenue by Player (2017-2022)
    4.2 Global Microbiome Therapeutics and Diagnostics Concentration Ratio (CR)
        4.2.1 Microbiome Therapeutics and Diagnostics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Microbiome Therapeutics and Diagnostics in 2021
        4.2.3 Global Microbiome Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Microbiome Therapeutics and Diagnostics Headquarters, Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Microbiome Therapeutics and Diagnostics Headquarters and Area Served
        4.3.2 Global Microbiome Therapeutics and Diagnostics Companies Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Microbiome Therapeutics and Diagnostics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Microbiome Therapeutics and Diagnostics Market Size by Company
        4.5.1 Top Microbiome Therapeutics and Diagnostics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Microbiome Therapeutics and Diagnostics Revenue by Players (2020, 2021 & 2022)

 5 Global Microbiome Therapeutics and Diagnostics Market Size by Region
    5.1 Global Microbiome Therapeutics and Diagnostics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Microbiome Therapeutics and Diagnostics Market Size by Region (2017-2028)
        5.2.1 Global Microbiome Therapeutics and Diagnostics Market Size by Region: 2017-2022
        5.2.2 Global Microbiome Therapeutics and Diagnostics Market Size by Region (2023-2028)

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Microbiome Therapeutics and Diagnostics Market Size YoY Growth 2017-2028
        6.1.2 North America Microbiome Therapeutics and Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Microbiome Therapeutics and Diagnostics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Microbiome Therapeutics and Diagnostics Market Size YoY Growth 2017-2028
        6.3.2 Europe Microbiome Therapeutics and Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Microbiome Therapeutics and Diagnostics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Microbiome Therapeutics and Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Microbiome Therapeutics and Diagnostics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Microbiome Therapeutics and Diagnostics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 4D Pharma
        7.1.1 4D Pharma Company Details
        7.1.2 4D Pharma Business Overview
        7.1.3 4D Pharma Microbiome Therapeutics and Diagnostics Introduction
        7.1.4 4D Pharma Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
        7.1.5 4D Pharma Recent Development
    7.2 Capsugel
        7.2.1 Capsugel Company Details
        7.2.2 Capsugel Business Overview
        7.2.3 Capsugel Microbiome Therapeutics and Diagnostics Introduction
        7.2.4 Capsugel Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
        7.2.5 Capsugel Recent Development
    7.3 Gusto Global
        7.3.1 Gusto Global Company Details
        7.3.2 Gusto Global Business Overview
        7.3.3 Gusto Global Microbiome Therapeutics and Diagnostics Introduction
        7.3.4 Gusto Global Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
        7.3.5 Gusto Global Recent Development
    7.4 MatriSys Bioscience
        7.4.1 MatriSys Bioscience Company Details
        7.4.2 MatriSys Bioscience Business Overview
        7.4.3 MatriSys Bioscience Microbiome Therapeutics and Diagnostics Introduction
        7.4.4 MatriSys Bioscience Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
        7.4.5 MatriSys Bioscience Recent Development
    7.5 Pierre Fabre
        7.5.1 Pierre Fabre Company Details
        7.5.2 Pierre Fabre Business Overview
        7.5.3 Pierre Fabre Microbiome Therapeutics and Diagnostics Introduction
        7.5.4 Pierre Fabre Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
        7.5.5 Pierre Fabre Recent Development
    7.6 Sunstone Capital
        7.6.1 Sunstone Capital Company Details
        7.6.2 Sunstone Capital Business Overview
        7.6.3 Sunstone Capital Microbiome Therapeutics and Diagnostics Introduction
        7.6.4 Sunstone Capital Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022)
        7.6.5 Sunstone Capital Recent Development

 8 Research Findings and Conclusion

 9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Microbiome Therapeutics and Diagnostics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Microbiome Therapeutics and Diagnostics Market Trends
    Table 3. Microbiome Therapeutics and Diagnostics Market Drivers
    Table 4. Microbiome Therapeutics and Diagnostics Market Challenges
    Table 5. Microbiome Therapeutics and Diagnostics Market Restraints
    Table 6. Global Microbiome Therapeutics and Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Microbiome Therapeutics and Diagnostics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Microbiome Therapeutics and Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Microbiome Therapeutics and Diagnostics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Microbiome Therapeutics and Diagnostics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Microbiome Therapeutics and Diagnostics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Microbiome Therapeutics and Diagnostics Revenue Share by Player, 2017-2022
    Table 13. Global Microbiome Therapeutics and Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Microbiome Therapeutics and Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Therapeutics and Diagnostics as of 2021)
    Table 15. Top Players of Microbiome Therapeutics and Diagnostics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Microbiome Therapeutics and Diagnostics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Microbiome Therapeutics and Diagnostics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Microbiome Therapeutics and Diagnostics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Microbiome Therapeutics and Diagnostics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Microbiome Therapeutics and Diagnostics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Microbiome Therapeutics and Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Microbiome Therapeutics and Diagnostics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Microbiome Therapeutics and Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Microbiome Therapeutics and Diagnostics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Microbiome Therapeutics and Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Microbiome Therapeutics and Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Microbiome Therapeutics and Diagnostics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. 4D Pharma Company Details
    Table 31. 4D Pharma Business Overview
    Table 32. 4D Pharma Microbiome Therapeutics and Diagnostics Product
    Table 33. 4D Pharma Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 34. 4D Pharma Recent Development
    Table 35. Capsugel Company Details
    Table 36. Capsugel Business Overview
    Table 37. Capsugel Microbiome Therapeutics and Diagnostics Product
    Table 38. Capsugel Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 39. Capsugel Recent Development
    Table 40. Gusto Global Company Details
    Table 41. Gusto Global Business Overview
    Table 42. Gusto Global Microbiome Therapeutics and Diagnostics Product
    Table 43. Gusto Global Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 44. Gusto Global Recent Development
    Table 45. MatriSys Bioscience Company Details
    Table 46. MatriSys Bioscience Business Overview
    Table 47. MatriSys Bioscience Microbiome Therapeutics and Diagnostics Product
    Table 48. MatriSys Bioscience Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 49. MatriSys Bioscience Recent Development
    Table 50. Pierre Fabre Company Details
    Table 51. Pierre Fabre Business Overview
    Table 52. Pierre Fabre Microbiome Therapeutics and Diagnostics Product
    Table 53. Pierre Fabre Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 54. Pierre Fabre Recent Development
    Table 55. Sunstone Capital Company Details
    Table 56. Sunstone Capital Business Overview
    Table 57. Sunstone Capital Microbiome Therapeutics and Diagnostics Product
    Table 58. Sunstone Capital Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million)
    Table 59. Sunstone Capital Recent Development
    Table 60. Research Programs/Design for This Report
    Table 61. Key Data Information from Secondary Sources
    Table 62. Key Data Information from Primary Sources
List of Figures
    Figure 1. Microbiome Therapeutics and Diagnostics Product Picture
    Figure 2. Global Microbiome Therapeutics and Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Microbiome Therapeutics and Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Microbiome Therapeutics and Diagnostics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Microbiome Therapeutics and Diagnostics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Microbiome Therapeutics and Diagnostics Market Share in Global 2017-2028
    Figure 7. Microbiome Therapeutics and Diagnostics Report Years Considered
    Figure 8. Product Picture of FMT
    Figure 9. Product Picture of Microbiome Drugs
    Figure 10. Product Picture of Others
    Figure 11. Global Microbiome Therapeutics and Diagnostics Market Share by Type in 2022 & 2028
    Figure 12. Global Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028)
    Figure 14. United States Microbiome Therapeutics and Diagnostics Market Share by Type in 2022 & 2028
    Figure 15. United States Microbiome Therapeutics and Diagnostics Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Microbiome Therapeutics and Diagnostics Market Share by Type (2017-2028)
    Figure 17. Product Picture of Stomach
    Figure 18. Product Picture of Respiratory Tract
    Figure 19. Product Picture of Other
    Figure 20. Global Microbiome Therapeutics and Diagnostics Market Share by Application in 2022 & 2028
    Figure 21. Global Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028)
    Figure 23. United States Microbiome Therapeutics and Diagnostics Market Share by Application in 2022 & 2028
    Figure 24. United States Microbiome Therapeutics and Diagnostics Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Microbiome Therapeutics and Diagnostics Market Share by Application (2017-2028)
    Figure 26. North America Microbiome Therapeutics and Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. United States Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Microbiome Therapeutics and Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Microbiome Therapeutics and Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. China Taiwan Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Microbiome Therapeutics and Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Microbiome Therapeutics and Diagnostics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. UAE Microbiome Therapeutics and Diagnostics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. 4D Pharma Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
    Figure 54. Capsugel Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
    Figure 55. Gusto Global Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
    Figure 56. MatriSys Bioscience Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
    Figure 57. Pierre Fabre Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
    Figure 58. Sunstone Capital Revenue Growth Rate in Microbiome Therapeutics and Diagnostics Business (2017-2022)
    Figure 59. Bottom-up and Top-down Approaches for This Report
    Figure 60. Data Triangulation
    Figure 61. Key Executives Interviewed

Market Analysis and Insights: Global and United States Microbiome Therapeutics and Diagnostics Market
This report focuses on global and United States Microbiome Therapeutics and Diagnostics market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Microbiome Therapeutics and Diagnostics market size is estimated to be worth US$  million in 2022 and is forecast to a readjusted size of US$  million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, FMT accounting for % of the Microbiome Therapeutics and Diagnostics global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Stomach was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

In United States the Microbiome Therapeutics and Diagnostics market size is expected to grow from US$  million in 2021 to US$  million by 2028, at a CAGR of % during the forecast period.

Global Microbiome Therapeutics and Diagnostics Scope and Market Size
Microbiome Therapeutics and Diagnostics market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Microbiome Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Microbiome Therapeutics and Diagnostics market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Microbiome Therapeutics and Diagnostics market is segmented into
    FMT
    Microbiome Drugs
    Others

Segment by Application, the Microbiome Therapeutics and Diagnostics market is segmented into
    Stomach
    Respiratory Tract
    Other

Regional and Country-level Analysis
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Microbiome Therapeutics and Diagnostics Market Share Analysis
Microbiome Therapeutics and Diagnostics market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Microbiome Therapeutics and Diagnostics business, the date to enter into the Microbiome Therapeutics and Diagnostics market, Revenue in Microbiome Therapeutics and Diagnostics Business (2017-2022) & (US$ Million) introduction, recent developments, etc.

The major vendors covered:
    4D Pharma
    Capsugel
    Gusto Global
    MatriSys Bioscience
    Pierre Fabre
    Sunstone Capital